UK Data: Medicines and drug safety

uk.co.reliness由 reliness.co.uk 發布官方發布者v1.5.0更新於 Nov 7, 2026

Medicine names, label text, safety reports, recalls, shortages and approvals from regulators

發布方自己的服務:UK Data: Compliance and finance checks

已驗證Streamable HTTP可網頁執行位置與生活安全與監控資料與分析

概覽

AI 產生的概覽

遠端 MCP 伺服器,讓助理取得美國 FDA 與 NLM 的藥品、醫材及安全資料:名稱、副作用、召回、短缺與核准資訊。

可以做什麼
  • 依名稱、品牌、通用成分或 NDC 查詢藥品,並比對或修正拼錯的藥名
  • 取得藥品適應症、禁忌症、藥理分類與品牌名稱
  • 查看已通報的副作用、膳食補充品與寵物用藥不良反應,以及醫材問題通報
  • 查詢 FDA 藥品短缺清單與 NDC 的有效或失效狀態
  • 檢索醫材召回、510(k) 許可、PMA 核准與醫材分類
適用情境
適合助理需要回答藥品身分、用途、副作用或供應狀況,或醫材安全與法規沿革的問題,並希望依據美國監管機關資料而非一般知識作答時使用。
執行需求
遠端 streamable HTTP 端點,無需本機安裝。免費每日額度不需帳號。可選的 Authorization 標頭可攜帶 bearer 金鑰以提高額度,免費金鑰須向提供者的金鑰端點申請。
安裝前請注意
可選的 Authorization 標頭含有金鑰,請避免寫入共用日誌。資料為美國監管資料,伺服器說明通報未經查證且無法證明因果關係,應視為訊號而非醫療建議。

安裝

在 SourceWeft 中

  1. 開啟 儀表板中的 UK Data: Medicines and drug safety,將其新增到工作區。
  2. 為需要使用其工具的對話啟用該服務。

Web executable,透過 Streamable HTTP。 遠端服務在工作區中設定後即可從網頁執行環境執行。

交給代理程式安裝

把這段提示詞貼上到 Claude Code、Codex、Cursor 等代理程式,或 SourceWeft 對話中。代理程式會讀取該伺服器的安裝指南,先向你展示發布者、端點和登入方式,經你同意後再把它新增到你的客戶端。金鑰不會寫進任何命令。

閱讀 https://sourceweft.com/mcp/uk.co.reliness%2Fmedicines-drugs/install.md,並按其中說明把這個 MCP 伺服器接入我的客戶端。修改任何設定之前,先告訴我它的發布者、端點和登入方式,等我確認。不要把 API 金鑰寫進命令或我會提交的檔案;問我金鑰應從哪裡取得。

檢視代理程式所依據的安裝指南

其他 MCP 客戶端

把它新增到你客戶端的 mcpServers 設定中。

{
  "mcpServers": {
    "uk-data-medicines-and-drug-safety": {
      "type": "http",
      "url": "https://ukdata.reliness.co.uk/mcp/medicines-drugs"
    }
  }
}

工具

18

fda_device_recalls

fda device recalls

Lists US FDA medical device recalls matching a product or firm name (for example "insulin pump", "CPAP", "Philips"), newest posted first, with the reason, root cause, what users were told to do, quantity and distribution. Useful for patients, clinicians and procurement teams checking whether a device type or maker has had recalls in the United States. Source: FDA device recall database via openFDA. US recalls only (not UK MHRA field safety notices); it does not confirm whether a specific serial number is affected, and this endpoint does not carry the Class I/II/III recall severity. (cost: 1 credit)

輸入參數limitquery

fda_device_510k_clearances

fda device 510k clearances

Finds US FDA 510(k) clearances by applicant (maker) and/or device name, newest decision first: K number, device, decision, clearance type, review time and device class. Answers "is this device FDA cleared?" and "what has this competitor had cleared recently?" for MedTech founders, regulatory consultants and investors. Source: FDA 510(k) premarket notification database via openFDA. Covers 510(k) only; high-risk Class III devices go through PMA (see fda_device_pma_approvals) and De Novo grants are not included. (cost: 1 credit)

輸入參數limitdeviceapplicant

fda_device_pma_approvals

fda device pma approvals

Finds US FDA premarket approval (PMA) decisions for high-risk Class III devices, including supplements, by applicant and/or trade name, newest first: PMA and supplement numbers, decision, supplement type and reason, and FDA's approval statement. For regulatory affairs teams and investors tracking approvals and changes for implants, heart valves, pacemaker leads and similar devices. Source: FDA PMA database via openFDA. Complements fda_device_510k_clearances; most results for large makers are supplements (manufacturing or labelling changes), not new devices. (cost: 1 credit)

輸入參數limitdeviceapplicant

fda_device_classification

fda device classification

Returns the FDA classification for a type of medical device: risk class (I, II or III), three-letter product code, regulation number, medical specialty, definition, the usual premarket route (510(k), PMA or exempt), and whether it is an implant or life-sustaining. Answers "what class is my device?" and "do I need a 510(k)?" for start-ups, importers and consultants. Source: FDA product classification database via openFDA. US classification only; it does not cover UK/EU (UKCA/CE) classes, and exemptions can carry limitations set out in the regulation. (cost: 1 credit)

輸入參數codelimitdevice

fda_device_problem_reports

fda device problem reports

Counts reports in the FDA MAUDE database for a device (generic type or brand name) by reported outcome: malfunction, injury, death or other. Gives journalists, litigation researchers and patients a quick sense of the reporting record for a device type, with the essential caveat attached. Source: FDA MAUDE medical device reports via openFDA. Counts are of reports, not confirmed incidents or causes, and cannot be used to rank how safe devices are; it does not return individual report narratives. (cost: 1 credit)

輸入參數device

fda_supplement_reactions

fda supplement reactions

Counts the reactions most often named in reports to the FDA (CAERS) about a food, drink, dietary supplement or cosmetic brand, for example "CELSIUS", most frequent first. Helps people asking about energy drinks, supplements and protein powders see what has been reported, with the caveat that reports are unverified. Source: FDA CFSAN Adverse Event Reporting System via openFDA. Counts are of reports mentioning each reaction, not proven side effects or rates, and small brands may have few or no reports. (cost: 1 credit)

輸入參數brandlimit

fda_pet_drug_reactions

fda pet drug reactions

Counts the reactions most often reported to the FDA for a veterinary medicine active ingredient, optionally in one species, for example carprofen in dogs, most frequent first. Answers pet owners' and vets' questions about what has been reported with flea, worming, pain and allergy medicines. Source: FDA Center for Veterinary Medicine adverse event reports via openFDA. Counts are reports, not confirmed side effects or rates; search by active ingredient (e.g. "Oclacitinib" rather than a brand name), and it covers US reports only. (cost: 1 credit)

輸入參數limitspeciesingredient

fda_drug_side_effects_reported

fda drug side effects reported

What side effects do people report for this medicine? Ranks the reactions most often named in reports to the FDA Adverse Event Reporting System (FAERS) for a medicine, with report counts. Popular with patients, journalists and pharmacovigilance work. Source: U.S. FDA openFDA FAERS. Reports are unverified, include every drug the patient was taking, and do not show the medicine caused the reaction or how common it is; label side effect rates are a different measure. (cost: 1 credit)

輸入參數namelimit

fda_drug_shortages

fda drug shortages

Is there a shortage of this medicine in the US? Lists entries on the FDA drug shortage list for a generic name, most recently updated first: each presentation's availability, status (current, resolved or to be discontinued), company, reason, estimated recovery note and posting dates. For pharmacists, procurement teams and patients. Source: U.S. FDA openFDA drug shortages. US supply only, not UK or NHS stock; the FDA list does not show local pharmacy stock. (cost: 1 credit)

輸入參數namelimitstatus

fda_ndc_lookup

fda ndc lookup

What is this NDC code, or what products exist for this medicine name? Looks up US medicine products in the FDA National Drug Code Directory by brand or generic name or by NDC (product 0573-0169, package 0573-0169-02, or the 11-digit billing form 00573-0169-02 / 00573016902): labeller, active ingredients and strengths, dosage form, route, OTC or prescription, approval reference and pack sizes. For pharmacy, billing and supply-chain work. Source: U.S. FDA openFDA NDC Directory. US-listed products only; name searches return finished medicines (not bulk ingredients), and delisted products are missing. (cost: 1 credit)

輸入參數ndcnamelimit

drug_name_match

drug name match

What is the standard name and ID for this medicine? Matches a messy drug name, brand, or name-plus-strength (e.g. 'zocor 10mg', 'metformin 500') to the closest US RxNorm concepts and their RxCUI codes, best match first, from the U.S. National Library of Medicine RxNav approximate-match service. Useful as the first step for medication lists, reconciliation and any tool that needs an RxCUI. Matches are ranked by text similarity, not checked clinically; only RxNorm-source names are returned, and non-US brand names may not match. (cost: 1 credit)

輸入參數termlimit

drug_spelling_suggest

drug spelling suggest

How do you spell this medicine? Suggests correctly spelt drug names for a misspelt or misheard one (e.g. 'ambienn' to 'ambien'), from the U.S. National Library of Medicine RxNorm spelling service. Useful for voice and OCR input, chat agents and anyone typing a prescription name from memory. Suggestions are names in the US RxNorm vocabulary only, without strengths; they say nothing about whether a drug is right for anyone. (cost: 1 credit)

輸入參數name

drug_brand_names

drug brand names

What brand names is this drug sold under? Lists the US brand names whose products contain a generic ingredient (e.g. simvastatin: Zocor, Vytorin, Flolipid), with RxCUI codes, from the U.S. National Library of Medicine RxNorm. Useful for travellers, carers and anyone comparing US and UK medicine names. Brands are US only (UK-only brands are not listed), the list includes combination products containing the ingredient, and it does not say which brands are currently marketed. (cost: 1 credit)

輸入參數generic

drug_generic_ingredient

drug generic ingredient

What is the generic name of this brand? Returns the active ingredient or ingredients of a US brand-name medicine (e.g. Zocor: simvastatin; Vytorin: ezetimibe and simvastatin), with RxCUI codes, from the U.S. National Library of Medicine RxNorm. Useful for patients, travellers and pharmacy staff looking for the generic equivalent. Brand names must be US ones known to RxNorm; it does not compare prices or say whether a generic is interchangeable for a given patient. (cost: 1 credit)

輸入參數brand

ndc_status

ndc status

Is this NDC still active? Checks a US National Drug Code against RxNorm and reports whether it is active, obsolete, alien or unknown, which product (RxCUI and name) it maps to, the source vocabularies that list it, and its month-by-month mapping history, from the U.S. National Library of Medicine RxNav. Useful for pharmacy, billing and claims work on old or unfamiliar codes. It covers US NDCs only and reflects RxNorm's records, which can lag FDA listing changes; it does not give price, packaging or supply. (cost: 1 credit)

輸入參數ndc

drug_listed_uses

drug listed uses

What conditions is this drug used for? Lists the conditions a drug is recorded as able to treat (may_treat) in the US Veterans Health Administration MED-RT reference, via the U.S. National Library of Medicine RxClass (e.g. metformin: Diabetes Mellitus, Type 2), with MeSH condition IDs. Useful for students, carers and agents wanting a short structured list rather than label prose. MED-RT is a reference terminology, not a full or current list of licensed indications, and off-label uses are not covered; not medical advice. (cost: 1 credit)

輸入參數name

drug_contraindicated_conditions

drug contraindicated conditions

Who should not take this drug? Lists the medical conditions a drug is recorded as contraindicated with (ci_with) in the US Veterans Health Administration MED-RT reference, via the U.S. National Library of Medicine RxClass (e.g. metformin: Renal Insufficiency, Liver Diseases, Acidosis), with MeSH condition IDs. Useful for students, carers and agents doing a first-pass reference check. It is a reference list, not the full warnings in a product label; drug-drug interactions are not covered, and anyone affected should check with a pharmacist or prescriber. (cost: 1 credit)

輸入參數name

drug_pharmacologic_class

drug pharmacologic class

What type of drug is this? Returns a drug's Established Pharmacologic Class as used in US FDA labelling (e.g. sertraline: Serotonin Reuptake Inhibitor; simvastatin: HMG-CoA Reductase Inhibitor), via the U.S. National Library of Medicine RxClass. Useful for patients, students and agents answering 'is it an SSRI / statin / opioid?'. Classes come from FDA product labels only, so older or non-US drugs may have none; it does not describe effects, safety or dosing. (cost: 1 credit)

輸入參數name

版本歷史

1
  1. v1.5.0最新Nov 7, 2026

評分

已滿足適用檢查項的 83%

該評分衡量此收錄條目的完整程度,依據註冊中心條目、端點與公開來源計算得出。它不是對伺服器本身的評價,也不表示伺服器安全或目前可用:可連通性是帶日期的檢查結果,評分也不包含安裝量或使用者評價。

  • 近 30 天內可連通必需25 分
  • 已宣告認證方式必需10 分
  • 已列出工具必需15 分
  • 描述必需15 分
  • 圖示10 分
  • 文件15 分

    請宣告包含 README 的 GitHub 儲存庫,或在 OAuth 受保護資源後設資料中提供 resource_documentation。

  • 授權條款不適用

    託管服務按其提供方的條款使用,因此這裡不要求授權條款。此檢查項不計入百分比。

其他 Reliness 整合